FAQs

A psychiatrist is a medical doctor (M.D. or D.O.) who specializes in the diagnosis and treatment of mental health conditions, as defined by the American Psychiatric Association. Psychiatrists assess both psychological and physical factors that may contribute to emotional or behavioral symptoms and develop individualized treatment plans when appropriate.

Psychiatric care involves a structured medical evaluation of emotional, behavioral, and cognitive concerns. During appointments, the clinician reviews medical history, family history, symptoms, and relevant life factors. Based on this information, a diagnosis may be considered and a treatment plan discussed. Treatment may include monitoring, therapy referral, lifestyle strategies, or medication when clinically indicated.

A psychiatrist is a medical doctor who completed medical school and residency training in psychiatry. Psychiatrists may prescribe medication and provide medical treatment for psychiatric conditions.

A psychologist typically holds a doctoral degree (Ph.D. or Psy.D.) in psychology and provides therapy, behavioral interventions, and psychological testing. Psychologists do not prescribe medication in most states.

Medication management is an ongoing clinical process in which a licensed medical provider evaluates the effectiveness, safety, and tolerability of prescribed psychiatric medications.

This process may include:

• Reviewing symptoms and treatment goals
• Discussing potential benefits and possible side effects
• Determining appropriate dosing
• Monitoring response over time
• Adjusting or tapering medication when clinically appropriate
• Scheduling follow-up visits

All medication decisions are individualized and made collaboratively between the patient and clinician.

A psychiatric evaluation is a comprehensive medical assessment used to better understand symptoms related to mood, behavior, thinking patterns, or functioning. The evaluation may include discussion of medical history, mental health history, family history, and current concerns.

Based on the evaluation, a clinician may consider possible diagnoses and recommend next steps, which could include monitoring, therapy referral, medication management, or additional assessment when appropriate.

The length of a psychiatric evaluation varies depending on the complexity of concerns and the amount of information reviewed. Initial evaluations are commonly scheduled for approximately 30 minutes, though timing may vary based on individual needs.

Both psychiatrists and psychologists may assess mental health concerns, but their roles differ.

A psychiatric evaluation focuses on medical diagnosis and treatment planning, which may include medication.

A psychological evaluation typically involves standardized testing to assess cognitive functioning, behavior, learning patterns, or emotional functioning. Results may be used to guide therapy, educational planning, or referral for medical evaluation when appropriate.

Most psychiatric medications are not considered addictive. Certain medications may carry a risk of dependence, which is carefully evaluated before prescribing. Providers monitor patients closely and discuss risks, benefits, and alternatives before initiating treatment.

Medication decisions are individualized and regularly reviewed to ensure safety and effectiveness.

Therapy can be helpful when a child is experiencing emotional, behavioral, academic, or social difficulties that are affecting daily functioning. A clinical evaluation can help determine whether therapy or another intervention may be appropriate.

Parents are often included in the process to support skill-building and progress outside of sessions.

The frequency and duration of counseling vary depending on the child’s needs, treatment goals, and response to therapy. Some children benefit from short-term therapy, while others may require longer-term support. Progress is reviewed periodically and adjusted collaboratively.

Ketamine is a medication that has been used in medical settings for decades. In mental health care, ketamine-based treatments may be considered for certain adults with treatment-resistant depression and other conditions when clinically appropriate.

Ketamist® refers to a non-IV delivery model administered under medical supervision. Suitability for this treatment requires a comprehensive psychiatric evaluation. Outcomes vary by individual, and ketamine therapy is not appropriate for all patients.

Ketamine-based treatment should only be administered under the supervision of a qualified medical professional following a full clinical screening.